Publications

2025

Da Silva Bortoleti BT, Quasem S, Maurer S, Zhong X, Pimenta R, Ribeiro de Lima Brandão L, Hernandez M, Fraidenburg M, Alves da Silva PH, Alvarez R, Chen BK, Diniz MA, Housman B, Flores RM, Brody R, Marron TU, Ferrari de Andrade L. A monoclonal antibody that inhibits the shedding of CD16a and CD16b and promotes antibody-dependent cellular cytotoxicity against tumors. Nature Communications 2025 Nov 11;16(1):9915.

 

2022

Alves da Silva, PH; Xing, S; Kotini, AG; Papapetrou, EP; Song, X; Wucherpfennig, KW, Mascarenhas J; Ferrari de Andrade, L*. MICA/B antibody induces macrophage-mediated immunity against acute myeloid leukemia. Blood 139(2):205-216, 2022. PMID: 34359073. *Corresponding author.

Maurer, S; Zhong, X; Prada, BD; Mascarenhas, J; Ferrari de Andrade, L.* The Latest Breakthroughs in Immunotherapy for Acute Myeloid Leukemia, with a Special Focus on NKG2D Ligands. International Journal of Molecular Sciences 2022, 23(24), 15,907. PMID: 36555547. *Corresponding author.

 

2020

Xing, S; Ferrari de Andrade, L*. NKG2D and MICA/B shedding: a ‘tag game’ between NK cells and malignant cells. Clinical & Translational Immunology 9(12), e1230, 2020. PMID: 33363734. *Corresponding author.

Maurer, S*; Ferrari de Andrade, L*. NK cell interaction with platelets and myeloid cells in the tumor milieu. Frontiers in Immunology 11, Article 608849, 2020. PMID: 33424862. *Corresponding authors.

Ferrari de Andrade, L*; Kumar, S; Luoma, AM; Ito, Y; Alves da Silva, PH; Pan, D; Pyrdol, JW; Yoon, CH; Wucherpfennig, KW.* Inhibition of MICA and MICB Shedding Elicits NK cell-mediated Immunity against Tumors Resistant to Cytotoxic T cells. Cancer Immunology Research 8:769-780, 2020. PMID: 32209637. *Corresponding authors.

 

2019

Ferrari de Andrade, L*; Lu, Y*; Luoma, A; Ito, Y; Pan, D; Pyrdol, JW; Yoon, CH; Yuan, G-C; Wucherpfennig, KW. Discovery of specialized NK cell populations infiltrating human melanoma metastases. JCI Insight 2019;4(23):e133103. PMID: 31801909. *Equal authorship.

 

2018

Ferrari de Andrade, L; Tay, RE; Pan, D; Luoma, AM; Ito, Y; Badrinath, S; Tsoucas, D; Franz, B; May Jr KF; Harvey, CJ; Kobold, S; Pyrdol, JW; Yoon, C; Yuan, G-C; Hodi, FS; Dranoff, G; Wucherpfennig, KW. Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity. Science 359, 1537-1542, 2018. PMID: 29599246.

 

2015

Guillerey, C*; Ferrari de Andrade, L*; Vuckovic, S; Miles, K; Ngiow, SF; Yong, MCR; Teng, MWL; Colonna, M; Ritchie, DS; Chesi, M; Bergsagel, PL; Hill, GR; Smyth, MJ; and Martinet, L. Immunosurveillance and therapy of multiple myeloma are CD226 dependent. The Journal of Clinical Investigation 125(5), 2077-2089, 2015. PMID: 26075821. *Equal authorship.

 

2014

Ferrari de Andrade, L; Ngiow, SF; Stannard, K; Rusakiewicz, S; Kalimutho, M; Khanna, KK; Tey, S-K; Takeda, K; Zitvogel, L; Martinet, L; and Smyth, MJ. NK cells are essential for the ability of BRAF inhibitors to control BRAFV600E-mutant metastatic melanoma. Cancer Research 74(24), 7298-7308, 2014. PMID: 25351955.

Ferrari de Andrade, L; Smyth MJ; and Martinet L. DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins. Immunology and Cell Biology 92, 237-244, 2014. PMID: 24343663.